Research Article
Evaluating Executive Functions in Patients with Juvenile Myoclonic Epilepsy Using Frontal Assessment Battery
Table 1
Demographic and clinical characteristics of patients and healthy controls.
| | (A) JME patients () | (B) Healthy controls () | value |
| | Age ()a | | | 0.005 | | Sex (male/female)b | 5/26 | 24/86 | 0.489 | | Disease duration ()a | | — | — | | Family history (, %)b | 14 (45.2%) | 4 (3.6%) | <0.00001 | | GTCS (, %)b | 26 (83.9%) | — | — | | Time from the last seizure (, %)b | | — | — | | Within 1 week | 9 (29%) | | | | A week or more | 22 (71%) | | | | Treatment (, %)b | | — | — | | Monotherapy | 18 (58.1%) | | | | Polytherapy | 13 (41.9%) | | | | Total FAB scorea | | | <0.00001 |
|
|
aStudent -test. bChi-square. JME: juvenile myoclonic epilepsy; GTCS: generalized tonic-clonic seizure; FAB: Frontal Assessment Battery; SD: standard deviation. |
